carmustine has been researched along with Glucosephosphate Dehydrogenase Deficiency in 3 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagone, AL | 1 |
| Burton, GM | 1 |
| Hohl, RJ | 1 |
| Kennedy, EJ | 1 |
| Frischer, H | 2 |
| Ahmad, T | 1 |
3 other studies available for carmustine and Glucosephosphate Dehydrogenase Deficiency
| Article | Year |
|---|---|
The effect of BCNU and adriamycin on normal and G6PD deficient erythrocytes.
Topics: Carmustine; Doxorubicin; Erythrocytes; Formates; Glucosephosphate Dehydrogenase Deficiency; Glutathi | 1979 |
Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
Topics: Carbon Dioxide; Carmustine; Decarboxylation; Erythrocytes; Glucose; Glucosephosphate Dehydrogenase D | 1991 |
Consequences of erythrocytic glutathione reductase deficiency.
Topics: Carmustine; Diamide; Dinitrochlorobenzene; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency; | 1987 |